Consensus statement on the treatment of septic shock.
Spapen
H
H
Intensieve Geneeskunde A.Z. VU Brussel, Belgium.
Damas
P
P
D'Orio
V
V
Sabbe
M
M
Vogelaers
D
D
Byl
B
B
Knockaert
D
D
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001530:Belgium; D002316:Cardiotonic Agents / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D017707:Erythrocyte Transfusion; D005440:Fluid Therapy; D006801:Humans; D007167:Immunotherapy; D009747:Nutritional Physiological Phenomena; D010437:Peptic Ulcer / Q000517:prevention & control; D012138:Respiratory Therapy; D018805:Sepsis / Q000628:therapy; D012772:Shock, Septic / Q000628:therapy*; D013312:Stress, Physiological / Q000517:prevention & control; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D020246:Venous Thrombosis / Q000517:prevention & control
D000900:Anti-Bacterial Agents; D002316:Cardiotonic Agents; D014662:Vasoconstrictor Agents; D004298:Dopamine